2021-12-23

Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease

Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease

Why do HPV tests with extended genotyping provide a more personalized assessment of an individual’s risk for developing cervical precancer? Discover the perspective of Molly Broache, Senior Manager, Medical Science Liaison at BD Life Sciences.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD Onclarity HPV Assay
Cervical Cancer | News & Updates
Press Release: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
Doctor giving patient brochure
Cervical Cancer | Articles & Publications
The Hill: What you can do to prevent cervical cancer
Guidelines: ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Cervical Cancer | Articles & Publications
Guidelines: ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors